Claudene George
Works at
Grants and prizes
R01Angiotensin II type 1 receptor autoantibody as a Biomarker for Identification and Targeted treatment of Individuals at risk for Alzheimer’s Disease (ABIT-AD)R01AG0928662026–203116 Sept 2026reporter.nih.gov